WHITTIER TRUST CO recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
Whittier Trust Co is an investment management firm based out of South Pasadena, California. The company was originally in 1935 and today offers a “breadth of financial services and expertise supported by an exceptional commitment to personal service reflecting our family office roots.” Whittier Trust is an independent company that is currently the “oldest and largest multifamily office headquartered on the West Coast.” Whittier Trust Co conducts its research both internally and externally in order to create a “unique vantage point that combines macroeconomic forecasts and individual company analysis” and focuses on the alternative investment market, especially on real estate, private equities, and oil and gas. The company invests most heavily in the finance sector, which alone makes up over a third of the firm’s total asset allocations, and also invests in the information technology, health care, consumer staples, consumer discretionary, industrials, and energy sectors, among other sectors to a lesser degree, in order of decreasing allocation. Whittier Trust holds its allocations for 11.5 quarters on average and holds its top 10 allocations, which makes up over a fifth of its total asset allocations, for approximately the same amount at 11.7 quarters on average. In the most recent quarter, Whittier Trust had a turnover rate of approximately 14.9%. The company’s top holdings include SPDR S&P 500 ETF Index Depositary Receipts, iShares Russell 2000 Index Fund, Apple Inc, Johnson & Johnson Co., JPMorgan Chase & Co., Exxon Mobil Corp., SPDR S&P MidCap 400 ETF Trust, and 3M Company, in order of decreasing allocations. Whittier Trust has developed a Wealth Management Framework in order to “give structure and a methodology to help analyze, evaluate and enhance your total wealth management picture.” The company focuses on growing and maintaining wealth by maximizing after tax and risk adjusted returns, focusing on the long term horizon.
As of the latest 13F report, the guru’s equity portfolio contained 1620 stocks valued at a total of $5.14Bil. The top holdings were AAPL(4.27%), MSFT(3.79%), and SPY(3.70%).
According to GuruFocus data, these were WHITTIER TRUST CO’s top five trades of the quarter.
Stryker Corp
WHITTIER TRUST CO reduced their investment in NYSE:SYK by 131,963 shares. The trade had a 0.5600000000000001% impact on the equity portfolio. During the quarter, the stock traded for an average price of $226.93.
On 01/25/2023, Stryker Corp traded for a price of $250.335 per share and a market cap of $94.73Bil. The stock has returned 2.16% over the past year.
GuruFocus gives the company a financial strength rating of 4 out of 10 and a profitability rating of 9 out of 10.
In terms of valuation, Stryker Corp has a price-earnings ratio of 38.93, a price-book ratio of 5.75, a price-earnings-to-growth (PEG) ratio of 10.81, a EV-to-Ebitda ratio of 28.04 and a price-sales ratio of 5.35.
The price-to-GF Value ratio is 0.93, earning the stock a GF Value rank of 6.
Charles Schwab Corp
During the quarter, WHITTIER TRUST CO bought 209,573 shares of NYSE:SCHW for a total holding of 281,649. The trade had a 0.34% impact on the equity portfolio. During the quarter, the stock traded for an average price of $77.61.
On 01/25/2023, Charles Schwab Corp traded for a price of $78.47 per share and a market cap of $146.48Bil. The stock has returned -9.96% over the past year.
GuruFocus gives the company a financial strength rating of 3 out of 10 and a profitability rating of 7 out of 10.
In terms of valuation, Charles Schwab Corp has a price-earnings ratio of 22.42, a price-book ratio of 5.50, a price-earnings-to-growth (PEG) ratio of 1.04 and a price-sales ratio of 7.15.
The price-to-GF Value ratio is 1.01, earning the stock a GF Value rank of 5.
iShares Core S&P Mid-Cap ETF
During the quarter, WHITTIER TRUST CO bought 59,261 shares of ARCA:IJH for a total holding of 418,274. The trade had a 0.28% impact on the equity portfolio. During the quarter, the stock traded for an average price of $240.73.
On 01/25/2023, iShares Core S&P Mid-Cap ETF traded for a price of $254.98 per share and a market cap of $67.19Bil. The stock has returned -0.09% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
In terms of valuation, iShares Core S&P Mid-Cap ETF has a price-earnings ratio of 13.48 and a price-book ratio of 2.29.
Citigroup Inc
WHITTIER TRUST CO reduced their investment in NYSE:C by 245,105 shares. The trade had a 0.22% impact on the equity portfolio. During the quarter, the stock traded for an average price of $45.43.
On 01/25/2023, Citigroup Inc traded for a price of $50.915 per share and a market cap of $98.61Bil. The stock has returned -17.32% over the past year.
GuruFocus gives the company a financial strength rating of 4 out of 10 and a profitability rating of 5 out of 10.
In terms of valuation, Citigroup Inc has a price-earnings ratio of 7.27, a price-book ratio of 0.54, a price-earnings-to-growth (PEG) ratio of 1.38 and a price-sales ratio of 1.32.
The price-to-GF Value ratio is 0.80, earning the stock a GF Value rank of 9.
ResMed Inc
WHITTIER TRUST CO reduced their investment in NYSE:RMD by 48,098 shares. The trade had a 0.22% impact on the equity portfolio. During the quarter, the stock traded for an average price of $219.7.
On 01/25/2023, ResMed Inc traded for a price of $230.72 per share and a market cap of $33.80Bil. The stock has returned 0.20% over the past year.
GuruFocus gives the company a financial strength rating of 8 out of 10 and a profitability rating of 10 out of 10.
In terms of valuation, ResMed Inc has a price-earnings ratio of 43.13, a price-book ratio of 9.84, a price-earnings-to-growth (PEG) ratio of 2.65, a EV-to-Ebitda ratio of 29.13 and a price-sales ratio of 9.36.
The price-to-GF Value ratio is 0.94, earning the stock a GF Value rank of 6.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
